Gerresheimer AG
Other OTCRecent
price
P/E
ratio
div
yld
- -
ROIC.AI
Capital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.- Similar Companies
- Business
- Gerresheimer AG is a global provider specializing in the manufacture and supply of pharmaceutical and healthcare packaging products. The company offers a broad portfolio including primary packaging made of glass and plastic; injection molding; glass tubular products; prefillable syringes; inhalers; insulin pens; bottles and ampoules; and other drug delivery systems. Gerresheimer serves pharmaceutical and biotech companies, medical device manufacturers, and cosmetic industries, operating across Europe, the Americas, and Asia. Founded in 1864 and headquartered in Düsseldorf, Germany, Gerresheimer AG focuses on integrated solutions for the pharmaceutical and healthcare sectors, emphasizing innovation and quality compliance. Its business is segmented into industries such as pharma packaging, drug delivery devices, and consumer packaging. The company also maintains subsidiaries and production sites worldwide to support its extensive client base. In recent major developments within the last 1-2 years, Gerresheimer AG has expanded its strategic alliances in the pharmaceutical delivery systems market, launched new high-tech product offerings such as advanced inhalers and prefillable syringes, and pursued business expansions to enhance manufacturing capabilities and geographic reach. The company has also undertaken operational improvements to optimize supply chain and production efficiency to meet rising global demand. These moves aim to strengthen its competitive position as a premier provider of pharmaceutical packaging solutions. Overall, Gerresheimer AG is a leading manufacturer of specialized pharmaceutical glass and plastic packaging and injection-molded products, delivering innovative drug delivery systems and packaging solutions primarily for pharmaceutical, biotech, and medical device industries on a global scale, with ongoing strategic initiatives driving growth and product development.
Gerresheimer rejects takeover bid from US packing firm Silgan, say sources
Gerresheimer delays 2025 results release to June, stock to be removed from SDAX
Diamond Hill International Strategy Q4 2025 Portfolio Review
Gerresheimer appoints Uwe Röhrhoff as new interim CEO
Gerresheimer finds 2024 revenue-recognition issues after external probe
Gerresheimer AG (GRRMY) Q3 2025 Earnings Call Transcript
Gerresheimer's shares fall 11% after another outlook cut
Gerresheimer cuts 2025 outlook again as Q3 disappoints
Gerresheimer shares tank as financial regulator suspects accounting flaws
Activist investor wants review at Gerresheimer after taking stake
Gerresheimer shares rise on plan to sell moulded glass business
Gerresheimer calls a halt to discussions on potential takeover
Gerresheimer cuts its 2025 revenue outlook for second time
AVI Calls for Changes at Gerresheimer
UK fund Asset Value Investor calls for changes at Gerresheimer
Gerresheimer cuts guidance for 2025 citing weak demand
Gerresheimer: Strong Growth Projections Make Stock Look Cheap
Gerresheimer AG (GRRMF) Q1 2025 Earnings Call Transcript
Gerresheimer's first-quarter results hit by low demand in moulded glass
KKR drops out of consortium seeking Gerresheimer takeover, Bloomberg News reports